Aprea Therapeutics
APRE
APRE
64 hedge funds and large institutions have $639M invested in Aprea Therapeutics in 2020 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 25 increasing their positions, 10 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
28% more funds holding
Funds holding: 50 → 64 (+14)
0.71% more ownership
Funds ownership: 3.2% → 3.91% (+0.71%)
Holders
64
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$71.9M | |
| 2 | +$48.6M | |
| 3 | +$13M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$12.2M |
| 5 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$6.14M |
Top Sellers
| 1 | -$24.8M | |
| 2 | -$21.5M | |
| 3 | -$10.8M | |
| 4 |
EI
EAM Investors
Solana Beach,
California
|
-$2.37M |
| 5 |
EGI
EAM Global Investors
Solana Beach,
California
|
-$1.33M |